| Name | Title | Contact Details |
|---|
Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.
Indiana Blood Center is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Excelth Inc is a New Orleans, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our name, Monogram, symbolizes the personalized focus of our services. While the application of the latest technology and data science is critical to our success, we never lose sight that healthcare is ultimately about trusted individual relationships between healthcare professionals and their patients. Unfortunately, individuals living with advanced CKD and ESRD are negatively impacted by well entrenched systematic forces such as perverse economic incentives, poor adherence to evidence-based care, and a lack of sensitivity to the negative impacts of social determinants of health. The 21st Century Cures Act is a seminal piece of legislation designed to shift individuals living with ESRD from FFS Medicare into managed care and reverse decades and decades of sub-optimal outcomes. Monogram was born with a vision to serve health plans and other sponsors of health care and solve for these systemic problems. Our mission is to improve clinical outcomes by predicting the onset of CKD and ESRD, slowing its progression, and reducing hospitalizations, morbidity and mortality. We are founded and operated by a core group of former government programs health plan executives, including our CEO, Michael Uchrin, a world-renown nephrologist and author of over 200 published pieces of research, Dr. Raymond Hakim, and former US Senator Bill Frist M.D., a retired cardiac surgeon and recognized leader for improving the quality of care provided to human beings across the world. We welcome all stakeholders in the CKD | ESRD ecosystem to join us in our mission to measurably improve outcomes for individuals living with these conditions.
Sun Healthcare Group, Inc. and its subsidiaries provide health care services primarily for senior population in the United States. It operates skilled nursing centers, which offer daily nursing, therapeutic rehabilitation, social, housekeeping, nutrition, and administrative services for individuals requiring certain assistance for activities in daily living. The company also operates assisted living centers that provide minimal nursing assistance, housekeeping, nutrition, laundry, and administrative services for individuals requiring minimal assistance for activities in daily living; and independent living centers, which offer security, housekeeping, nutrition, and limited laundry services for individuals requiring no assistance for activities in daily living. In addition, it operates mental health centers, which provide inpatient and outpatient behavioral health services for adults and children, as well as offers hospice services, including palliative care, social services, pain management, and spiritual counseling in 11 states. Further, the company offers rehabilitation therapy services, including speech pathology, physical therapy, and occupational therapy. Additionally, it offers temporary medical staffing comprising licensed therapists in the areas of physical, occupational, and speech therapy; nurses; pharmacists, pharmacist technicians, and medical imaging technicians physicians; and related medical personnel for hospitals and other providers, skilled nursing centers, schools, and prisons in 40 states. The company was founded in 1989 and is based in Irvine, California. As of December 3, 2012, Sun Healthcare Group, Inc. operates as a subsidiary of Genesis HealthCare LLC.